Projects

Activation and Regulation Mechanisms of cGMP-dependent Protein Kinase I and II
Role: Primary Investigator
Funding Agency: National Institute of Health, GM
Dates of Funding; June 1, 2015 - July 1, 2019 (Competing Renewal)
Annual Direct Cost: $258,000
Grant Number: 2R01GM090161

The Role of DIRAS3 (ARHI) in Initiating Autophagy and Tumor Dormancy
Role: Co-Primary Investigator
Funding Agency : Cancer Prevention and Research Institute of Texas (CPRIT)
Dates of Funding : Aug. 31, 2014 - Aug. 30, 2017
Annual Direct Cost : $50,000
Grant Number: RP100421

Activation and Regulation Mechanisms of cGMP-dependent Protein Kinase I and II
Role: Primary Investigator
Funding Agency: National Institute of Health, GM
Dates of Funding: July 1, 2015 - July 1, 2019 (Competing Renewal)
Annual Direct Cost: $258,000
Grant Number: 2R01GM090161

The Role of DIRAS3 (ARHI) in Initiating Autophagy and Tumor Dormancy
Role: Co-Primary Investigator
Funding Agency: Cancer Prevention and Research Institute of Texas (CPRIT)
Dates of Funding: Aug. 31, 2014 - Aug. 30, 2017
Annual Direct Cost: $50,000

Molecular targeting mechanisms of cGMP-dependent protein kinases using peptide arrays and X-ray crystallography
Role: Primary Investigator
Funding Agency: National Institute of Health, GM
Dates of Funding: July 1, 2010 - July 1, 2015
Annual Direct Cost: $198,000
Grant Number: R01GM090161

Targeting cGMP kinases to develop new therapeutics for hypertensive diseases
Role: Primary Investigator
Funding Agency: National Heart, Lung, and Blood Institute
Dates of Funding July 17, 2012 - June 30, 2014
Annual Direct Cost: $145,000
Grant Number: R21 HL111953

Molecular targeting mechanisms of cGMP-dependent protein kinases
Role: Primary Investigator
Dates of Funding: July 17, 2009 - June, 30, 2010 - June 30, 2010
Funding Agency: American Heart Association
Annual Direct Cost : $100,000